| abstract |
R 1 to R 5 , B and Z as stereochemically isomeric forms and HBV replication inhibitors of formula (I) comprising salts, hydrates, and solvates thereof have the meanings as defined herein. The present invention also relates to methods of preparing the compounds, pharmaceutical compositions containing them and their use alone or in combination with other HBV inhibitors in HBV therapy. |